Ad
related to: Vertex PharmaceuticalsRegulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
- Drug Products
A sterile injectables network with
global reach for small molecules...
- OSD Manufacturing
Learn More About The Services
Offered at pfizercentreone.
- Injectable Manufacturing
Learn More About The Injectable
Manufacturing Process At Pfizer.
- Sterile Injectable
Learn About The Benefits Of Using
Sterile Injectables.
- Forecast support
Theres no limit to what we can
achieve together Suppliers of...
- API Manufacturing
We Offer A Full Range Of API
Manufacturing Services.
- Drug Products
Search results
Vertex is a biotechnology company that develops medicines for serious diseases, such as cystic fibrosis, sickle cell disease, and kidney disease. Learn about its latest news, clinical trials, acquisitions, and corporate responsibility report.
- Our Approved Medicines
Our Approved Medicines - Vertex Pharmaceuticals | Home
- Our Company
In 2023, we ranked #12 in the Mega Employer category. Vertex...
- Our Science
Our Science - Vertex Pharmaceuticals | Home
- Patients
Patients - Vertex Pharmaceuticals | Home
- Responsibility
At Vertex, giving back includes providing opportunities to...
- Our Approved Medicines
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko,...
Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.
Jan 30, 2024 · Vertex announces positive results from Phase 3 program for VX-548, a selective NaV1.8 inhibitor, in the treatment of moderate-to-severe acute pain. VX-548 showed statistically significant improvement in pain compared to placebo and was safe and well tolerated in surgical and non-surgical pain conditions.
Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) patients 12 years and older with recurrent vaso-occlusive crises. It is the first CRISPR-based gene-editing therapy approved in the U.S. and offers the potential of a functional cure by increasing fetal hemoglobin production.
People also ask
What does vertex do?
Where is vertex located?
Who is Vertex Pharmaceuticals?
What diseases does vertex treat?
Ad
related to: Vertex PharmaceuticalsRegulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
